Initial cellular targets and eventual genomic changes in multistage carcinogenesis.
D000818:Animals; D029742:Caenorhabditis elegans Proteins; D002273:Carcinogens / Q000633:toxicity*; D002352:Carrier Proteins; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002869:Chromosome Aberrations; D004247:DNA / Q000032:analysis; D004261:DNA Replication / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D009857:Oncogenes; D010703:Phorbol Esters / Q000378:metabolism; D011493:Protein Kinase C; D011955:Receptors, Drug; D011971:Receptors, Immunologic / Q000378:metabolism; D012878:Skin Neoplasms / Q000139:chemically induced
D029742:Caenorhabditis elegans Proteins; D002273:Carcinogens; D002352:Carrier Proteins; D010703:Phorbol Esters; D011955:Receptors, Drug; D011971:Receptors, Immunologic; C083141:phorbol ester binding protein; C027776:phorbol ester receptor; D004247:DNA; D011493:Protein Kinase C